RAINIER THERAPEUTICS
Rainier Therapeutics is a developer of cancer therapeutics technology intended to offer advanced targeted therapy for bladder cancer.The company's technology uses Vofatamab, a human monoclonal antibody that targets and specifically blocks the activity of FGFR3 (fibroblast growth factor receptor 3), enabling medical practitioners to treat patients with early stage and metastatic bladder cancer effectively.
RAINIER THERAPEUTICS
Industry:
Biopharma Biotechnology Developer Platform Medical Therapeutics
Founded:
2010-01-01
Address:
San Leandro, California, United States
Country:
United States
Website Url:
http://www.rainierrx.com
Total Employee:
11+
Status:
Active
Contact:
+1-510-878-2486
Email Addresses:
[email protected]
Total Funding:
89 M USD
Technology used in webpage:
Viewport Meta IPhone / Mobile Compatible SPF SSL By Default LetsEncrypt Nginx Microsoft Exchange Online Office 365 Mail GoDaddy DNS Google
Similar Organizations
Affimed
Affimed Therapeutics is focused on developing recombinant antibody therapeutics for the treatment of cancer and other diseases.
BioLife Solutions
BioLife Solutions is located in Bothell, Washington, on a high-tech campus that has its roots as a dairy farm.
Cairn Therapeutics
Cairn Therapeutics transforms the treatment of cancer by overcoming the current limitations of the current therapies.
CinderBio
CinderBio produces the world's most stable enzymes from amazing microbes that thrive in hot acidic volcanic waters around the globe.
Abterra Biosciences
Abterra Biosciences mines the natural immune repertoire to discover the next generation of antibody therapeutics.
Entrada Therapeutics
Entrada Therapeutics is a developer of novel therapeutics intended to treat devastating diseases.
HepaTx
Hepatx is developing regenerative medicine solutions.
LiveLeaf
LiveLeaf develops therapeutic products designed to turn the biochemistry of plant immunity into sustainable one.
Marker Therapeutics
Marker Therapeutics is a clinical-stage developer of a transformative, non-genetically engineered, multi-antigen T cell therapy platform.
Mosaic Biosciences
Mosaic Biosciences is a developer of synthetic extracellular materials used to support natural tissue regeneration.
Phico Therapeutics
Phico Therapeutics is a developer of novel platform technology designed to overcome antibacterial resistance.
Remedy Plan Therapeutics
Remedy Plan is a pre-clinical cancer therapeutics company developing first-in-class small molecule drugs that differentiate cancer cells.
ScarTec Therapeutics
ScarTec Therapeutics develops novel peptide-based technology for scar-free healing.
Scioto Biosciences
Scioto is a developer of Activated Bacterial Therapeutics platform.
SymbioCellTech
SymbioCellTech developer of cell based therapies designed to provide the world.
Tetragenetics
Tetragenetics helps people seeking a cost-effective alternative platform technology for the production of genetically engineered proteins.
Thermaquil
Thermaquil is developing the ideal reversible nerve block device to manage severe pain without drugs or electric stimulation.
Valitor
Valitor has developed novel methods of modifying therapeutic proteins to achieve substantial control over their pharmacological properties..
ViewPoint Therapeutics
ViewPoint Therapeutics is a developer of crystallin stabilizers intended to prevent and treat cataracts and presbyopia.
Current Advisors List
Current Employees Featured
Founder
Investors List
Tekla Capital Management
Tekla Capital Management investment in Series B - Rainier Therapeutics
Inkef
Inkef investment in Series B - Rainier Therapeutics
Life Sciences Partners
Life Sciences Partners investment in Series B - Rainier Therapeutics
Sofinnova Investments
Sofinnova Investments investment in Series B - Rainier Therapeutics
Sectoral Asset Management
Sectoral Asset Management investment in Series B - Rainier Therapeutics
Ysios Capital
Ysios Capital investment in Series B - Rainier Therapeutics
HealthCap
HealthCap investment in Series B - Rainier Therapeutics
Ysios Capital
Ysios Capital investment in Series B - Rainier Therapeutics
Life Sciences Partners
Life Sciences Partners investment in Series B - Rainier Therapeutics
Sofinnova Investments
Sofinnova Investments investment in Series B - Rainier Therapeutics
Official Site Inspections
http://www.rainierrx.com
- Host name: 206.244.209.35.bc.googleusercontent.com
- IP address: 35.209.244.206
- Location: Mountain View United States
- Latitude: 37.4043
- Longitude: -122.0748
- Metro Code: 807
- Timezone: America/Los_Angeles
- Postal: 94043
